Clinical trial ongoing at the Institute:
- Prospective follow-up of a cohort of patients with mitochondrial diseases
- REN001-201 / STRIDE: A double-blind, placebo-controlled study to evaluate the efficacy and safety of 24 weeks treatment with REN001 in patients with primary mitochondrialmyopathy (PMM)
Acronym |
Prospective follow-up |
REN001-201 / STRIDE |
| Intervention | – | REN001 |
| Principal investigators |
Pascal Laforêt | Tanya Stojkovic |
| Sponsor | AIM | Reneo Pharma Ltd. |
| Study status | Ongoing | In preparation |
| Recruitment status | Ongoing | In preparation |
| Population | Adult | Adult |
| Contact | n.benammar@institut-myologie.org | |
| + infos on clinical trials.gov |
